Vitamin D and Disease Severity in Multiple Sclerosis—Baseline Data From the Randomized Controlled Trial (EVIDIMS)
Open Access
- 25 February 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 11, 129
Abstract
Objective: To investigate the associations between hypovitaminosis D and disease activity in a cohort of relapsing remitting multiple sclerosis (RRMS) and clinically isolated syndrome (CIS) patients. Methods: In 51 RRMS and 2 CIS patients on stable interferon-β-1b (IFN-β-1b) treatment recruited to the EVIDIMS study (Efficacy of Vitamin D Supplementation in Multiple Sclerosis (NCT01440062) baseline serum vitamin D levels were evaluated. Patients were dichotomized based on the definition of vitamin D deficiency which is reflected by a < 30 vs. ≥ 30 ng/ml level of 25-hydroxyvitamin D (25(OH)D). Possible associations between vitamin D deficiency and both clinical and MRI features of the disease were analyzed. Results: Median (25, 75% quartiles, Q) 25(OH)D level was 18 ng/ml (12, 24). Forty eight out of 53 (91%) patients had 25(OH)D levels < 30 ng/ml (p < 0.001). Patients with 25(OH)D ≥ 30 ng/ml had lower median (25, 75% Q) T2-weighted lesion counts [25 (24, 33)] compared to patients with 25(OH)D < 30 ng/ml [60 (36, 84), p = 0.03; adjusted for age, gender and disease duration: p < 0.001]. Expanded disability status scale (EDSS) score was negatively associated with serum 25(OH)D levels in a multiple linear regression, including age, sex, and disease duration (adjusted: p < 0.001). Interpretation: Most patients recruited in the EVIDIMS study were vitamin D deficient. Higher 25(OH)D levels were associated with reduced T2 weighted lesion count and lower EDSS scores.Keywords
This publication has 47 references indexed in Scilit:
- Guidelines for Preventing and Treating Vitamin D Deficiency and Insufficiency RevisitedThe Journal of Clinical Endocrinology & Metabolism, 2012
- IOM Committee Members Respond to Endocrine Society Vitamin D GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2012
- A randomised, double blind, placebo controlled trial with vitamin D3as an add on treatment to interferon β-1b in patients with multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trialTrials, 2012
- An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple SclerosisNeuroImage, 2012
- Association of UV radiation with multiple sclerosis prevalence and sex ratio in FranceNeurology, 2011
- Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada (summary)Canadian Medical Association Journal, 2010
- Multiple sclerosisThe Lancet, 2008
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- Serum 25-Hydroxyvitamin D Levels and Risk of Multiple SclerosisJAMA, 2006